Early Phase 1WithdrawnINTERVENTIONAL
Effect of Short Term Ovarian Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess
ClinicalTrials.gov · NCT01422096 · Registry updated: 2018-07-19
- Condition / research focus
- Hyperandrogenemia; Obesity; Polycystic Ovary Syndrome
- Sponsor
- University of Virginia
- Countries with listed sites
- United States
- Registry dates and results
- Start: 2018-06-01. Completion: 2018-07-17 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- Leuprolide (drug) — also listed as: Depot Lupron
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- University of Virginia Center for Research in Reproduction
Charlottesville, Virginia, United States
Site recruitment: Not reported